Wolverine Trading’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,757
| Closed | -$227K | – | 6708 |
|
|
2024
Q3 | $202K | Sell |
2,757
-340
| -11% | -$25.6K | 0.01% | 4086 |
|
|
2024
Q2 | $212K | Sell |
3,097
-1,420
| -31% | -$98.5K | ﹤0.01% | 3794 |
|
|
2024
Q1 | $313K | Buy |
+4,517
| New | +$310K | ﹤0.01% | 3310 |
|
|
2023
Q2 | – | Sell |
-8,602
| Closed | -$482K | – | 6015 |
|
|
2023
Q1 | $482K | Buy |
+8,602
| New | +$416K | 0.01% | 2538 |
|
|
2022
Q1 | – | Sell |
-5,445
| Closed | -$283K | – | 7429 |
|
|
2021
Q4 | $284K | Sell |
5,445
-2,645
| -33% | -$111K | ﹤0.01% | 4227 |
|
|
2021
Q3 | $290K | Buy |
+8,090
| New | +$281K | 0.01% | 4766 |
|
|
2020
Q4 | – | Sell |
-8,656
| Closed | -$227K | – | 6176 |
|
|
2020
Q3 | $221K | Sell |
8,656
-3,690
| -30% | -$84.2K | 0.01% | 3763 |
|
|
2020
Q2 | $311K | Buy |
+12,346
| New | +$250K | 0.02% | 3299 |
|
|
2020
Q1 | – | Sell |
-16,935
| Closed | -$368K | – | 5940 |
|
|
2019
Q4 | $570K | Buy |
+16,935
| New | +$203K | 0.01% | 2953 |
|
|
2019
Q3 | – | Sell |
-16,816
| Closed | -$161K | – | 5695 |
|
|
2019
Q2 | $218K | Sell |
16,816
-884
| -5% | -$11.3K | 0.01% | 3628 |
|
|
2019
Q1 | $216K | Buy |
17,700
+1,676
| +10% | +$21.4K | 0.01% | 3737 |
|
|
2018
Q4 | $181K | Sell |
16,024
-18,578
| -54% | -$300K | 0.01% | 3746 |
|
|
2018
Q3 | $751K | Buy |
34,602
+23,233
| +204% | +$486K | 0.02% | 2653 |
|
|
2018
Q2 | $239K | Hold |
11,369
| – | – | 0.01% | 4124 |
|
|
2018
Q1 | $239K | Buy |
11,369
+1,055
| +10% | +$20.6K | 0.01% | 4124 |
|
|
2017
Q4 | $149K | Buy |
+10,314
| New | +$159K | ﹤0.01% | 4310 |
|
|
2016
Q4 | – | Sell |
-32,106
| Closed | -$453K | – | 6050 |
|
|
2016
Q3 | $495K | Buy |
+32,106
| New | +$1.3M | 0.03% | 2579 |
|
Other funds holding ITCI
PCM
HI
DKCM
UOC
FCM
